These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 99283)

  • 41. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical mucus peroxidase is a reliable indicator for ovulation in humans.
    Anderson WA; Ahluwalia BS; Westney LS; Burnett CC; Rüchel R
    Fertil Steril; 1984 May; 41(5):697-702. PubMed ID: 6325254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulation.
    Humphries J; Wan YP; Folkers K; Bowers CY
    Biochem Biophys Res Commun; 1976 Oct; 72(3):939-44. PubMed ID: 791291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonism of luteinizing hormone release and of ovulation by an analog of the luteinizing hormone-releasing hormone.
    Yardley JP; Foell TJ; Beattie CW; Grant NH
    J Med Chem; 1975 Dec; 18(12):1244-7. PubMed ID: 1104833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
    Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum gonadotropin concentrations and ovarian response in ewes treated with analogs to LH-RH/FSH-RH.
    Kinder JE; Adams TE; Nett TM; Coy DH; Schally AV; Reeves JJ
    J Anim Sci; 1976 May; 42(5):1220-6. PubMed ID: 773913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental studies of LH-RH and its analogs in ovulation induction].
    Kumasaka T
    Horumon To Rinsho; 1976; 24(8):787-95. PubMed ID: 788964
    [No Abstract]   [Full Text] [Related]  

  • 48. Pituitary responsiveness to synthetic luteinizing hormone releasing hormone (LH-RH) during the menstrual cycle and in female hypogonadism.
    Nakano R; Kotsuji F; Tojo S
    Br J Obstet Gynaecol; 1975 Oct; 82(10):805-11. PubMed ID: 1103960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of synthetic hypothalamic gonadotropin-releasing hormone (FSH-LH-RH) in anovulatory sterility.
    Zanartu J; Dabancens A; Kastin AJ; Schally AV
    Fertil Steril; 1974 Feb; 25(2):160-9. PubMed ID: 4590125
    [No Abstract]   [Full Text] [Related]  

  • 50. Normal ovulatory cycles in one subject receiving daily hypophyseal stimulation by LH-RH at two levels.
    Thomas K; Donnez J; Ferin J
    Contraception; 1975 Mar; 11(3):271-7. PubMed ID: 1090412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity.
    Fujino M; Yamazaki I; Kobayashi S; Fukuda T; Shinagawa S; White WF; Rippel RH
    Biochem Biophys Res Commun; 1974 Apr; 57(4):1248-56. PubMed ID: 4598337
    [No Abstract]   [Full Text] [Related]  

  • 52. [LH-RH therapy in menstruation and ovulation disorders].
    Iizuka R; Nakamura S; Kurokawa H; Matsumoto S; Saito K
    Horumon To Rinsho; 1973 Sep; 21(9):935-43. PubMed ID: 4587496
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of folliculogenesis in the monkey following early follicular phase administration of an LRH agonist.
    Wilks JW
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):538-43. PubMed ID: 6433613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.
    Fraser HM
    J Endocrinol; 1981 Dec; 91(3):525-30. PubMed ID: 6799604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroendocrine control of human ovulation.
    Burger HG
    Int J Fertil; 1981; 26(3):153-60. PubMed ID: 6118335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Further observations on the therapy of anovulatory infertility with synthetic luteinizing hormone-releasing hormone.
    Zarate A; Canales ES; Soria A; Gonzalez A; Schally AV; Kastin AJ
    Fertil Steril; 1974 Jan; 25(1):3-10. PubMed ID: 4589422
    [No Abstract]   [Full Text] [Related]  

  • 58. The interrelationship between progesterone and luteinizing hormone during the ovulation cycle of the hen (Gallus domesticus).
    Etches RJ; Cunningham FJ
    J Endocrinol; 1976 Oct; 71(1):51-8. PubMed ID: 789807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of the preovulatory surge of LH and FSH and of ovulation by anti-LH-RH serum in rats.
    Arimura A; Debeljuk L; Schally AV
    Endocrinology; 1974 Jul; 95(1):323-5. PubMed ID: 4134210
    [No Abstract]   [Full Text] [Related]  

  • 60. A new category of ovulation inhibitors: linear LH-RH analogues having more than ten residues.
    Wasiak T; Humphries J; Folkers K; Bowers CY
    Biochem Biophys Res Commun; 1979 Feb; 86(3):843-8. PubMed ID: 371622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.